🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a clinical trial to evaluate the feasibility and safety of giving t...
Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Start Date
2023-10-04
Trial ID
NCT05934838
Treatments Being Tested
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Start Date
2015-10
Trial ID
NCT02580747
Treatments Being Tested
This clinical study is to investigate the safety and tolerability of CAR mo...
Status
Terminated
Location
Shanghai Zhongshan Hospital
Start Date
2019-05-16
Trial ID
NCT03960060
Treatments Being Tested
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749
This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
Status
Completed
Location
City of Hope
Start Date
2021-07-29
Trial ID
NCT05075603
Treatments Being Tested
Chimeric antigen receptor (CAR)-modified T cells can mediate long-term dura...
Status
Unknown
Location
Sanbo Brain Hospital Capital Medical University
Start Date
2016-07
Trial ID
NCT02844062
Treatments Being Tested
Relapsed or refractory acute leukemia (R/R AL) is a life-threatening blood ...
Status
Not Yet Recruiting
Location
Department of Hematology, Zhujiang Hospital, Southern Medical University
Start Date
2026-08-01
Trial ID
NCT07696481
Treatments Being Tested
The purpose of this study is to infusion CD19 CAR-T cells to the patients w...
Status
Unknown
Location
The First Affiliated Hospital of Henan University of Science and Technology
Start Date
2017-08-16
Trial ID
NCT03263208
Treatments Being Tested
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Start Date
2025-09-01
Trial ID
NCT07117305
Treatments Being Tested